| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Fennec Pharmaceuticals Inc (TO: FRX)
FRX Technical Analysis
4
| As on 9th Jan 2026 FRX STOCK Price closed @ 10.85 and we RECOMMEND Buy for LONG-TERM with Stoploss of 8.19 & Strong Buy for SHORT-TERM with Stoploss of 8.85 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FRXSTOCK Price
| Open | 10.85 | Change | Price | % |
| High | 10.85 | 1 Day | 0.69 | 6.79 |
| Low | 10.85 | 1 Week | 0.22 | 2.07 |
| Close | 10.85 | 1 Month | -1.15 | -9.58 |
| Volume | 1735 | 1 Year | 2.36 | 27.80 |
| 52 Week High 13.75 | 52 Week Low 7.02 | ||||
TO Canada Most Active Stocks
| YRI | 7.89 | 0.13% |
| TD | 131.17 | 0.02% |
| CVE | 22.87 | 0.75% |
| CNQ | 44.62 | 2.08% |
| UEX | 0.50 | 16.28% |
| FF | 0.56 | 3.70% |
| SJR-B | 40.48 | 0.02% |
| MEG | 30.89 | 0.72% |
| CXB | 2.99 | -0.33% |
| TRP | 74.90 | 0.98% |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
| FRX Daily Charts |
FRX Intraday Charts |
Whats New @ Bazaartrend |
FRX Free Analysis |
|
|
FRX Important Levels Intraday
| RESISTANCE | 10.85 |
| RESISTANCE | 10.85 |
| RESISTANCE | 10.85 |
| RESISTANCE | 10.85 |
| RESISTANCE | 10.85 |
| RESISTANCE | 10.85 |
| RESISTANCE | 10.85 |
| RESISTANCE | 10.85 |
FRX Forecast January 2026
| 4th UP Forecast | 14.99 |
| 3rd UP Forecast | 13.66 |
| 2nd UP Forecast | 12.84 |
| 1st UP Forecast | 12.02 |
| 1st DOWN Forecast | 9.68 |
| 2nd DOWN Forecast | 8.86 |
| 3rd DOWN Forecast | 8.04 |
| 4th DOWN Forecast | 6.71 |
FRX Weekly Forecast
| 4th UP Forecast | 11.83 |
| 3rd UP Forecast | 11.52 |
| 2nd UP Forecast | 11.32 |
| 1st UP Forecast | 11.13 |
| 1st DOWN Forecast | 10.57 |
| 2nd DOWN Forecast | 10.38 |
| 3rd DOWN Forecast | 10.18 |
| 4th DOWN Forecast | 9.87 |
FRX Forecast2026
| 4th UP Forecast | 23.97 |
| 3rd UP Forecast | 19.76 |
| 2nd UP Forecast | 17.16 |
| 1st UP Forecast | 14.56 |
| 1st DOWN Forecast | 7.14 |
| 2nd DOWN Forecast | 4.54 |
| 3rd DOWN Forecast | 1.94 |
| 4th DOWN Forecast | -2.27 |
Fennec Pharmaceuticals Inc ( TO Canada Symbol : FRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FRX Business Profile
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina. Address: 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service